Episodes of (Dis)Connected Consciousness in ICU Survivors

NCT ID: NCT07048951

Last Updated: 2025-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-01

Study Completion Date

2027-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This single-center observational study aims to describe the incidence of episodes of connected consciousness and disconnected consciousness (including near-death experience (NDE) and out-of-body experiences) in patients who survived a prolonged stay of at least 7 days in the intensive care unit (ICU) and who had at least one episode of pharmacological or non-pharmacological coma. The investigators are also investigating the risk factors related to these episodes of consciousness. A follow-up at six months aims to explore the long-term psychological implications of these episodes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Consciousness Near Death Experience ICU Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Survivors of prolonged ICU (≥7days) stay with episode(s) of pharmacological/non-pharmacological coma

The Near-Death Experience Content (NDE-C) scale

Intervention Type DIAGNOSTIC_TEST

Questionnaire to detect occurence of NDE. A NDE is identified if score \> or = 27/80

Threat perception measure

Intervention Type OTHER

7 items scale investigating the participant's psychological vulnerability during their stay at the ICU

Interview about the participant's memories of the ICU

Intervention Type OTHER

Participants will be asked to describe any dream, hallucination, or any other unusual experience they can recall from their stay at the ICU.

Additionally, the participants will be asked to describe any memory they have of the environment of the ICU, such as the appearance of the room, medical staff, family visiting, noises, etc.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The Near-Death Experience Content (NDE-C) scale

Questionnaire to detect occurence of NDE. A NDE is identified if score \> or = 27/80

Intervention Type DIAGNOSTIC_TEST

Threat perception measure

7 items scale investigating the participant's psychological vulnerability during their stay at the ICU

Intervention Type OTHER

Interview about the participant's memories of the ICU

Participants will be asked to describe any dream, hallucination, or any other unusual experience they can recall from their stay at the ICU.

Additionally, the participants will be asked to describe any memory they have of the environment of the ICU, such as the appearance of the room, medical staff, family visiting, noises, etc.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients who survived a ≥7 days stay in the intensive care unit
* Experienced a pharmacological or non-pharmacological episode of loss of consciousness
* French speaking

Exclusion Criteria

* Refusal
* Chronic disorder of consciousness
* Confusion or delirium
* Deafness
* Blindness
* Aphasia
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Liege

OTHER

Sponsor Role collaborator

University of Liege

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU of Liège

Liège, Liège, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Charlotte Martial, PhD

Role: CONTACT

+3243233612

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-254

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prognosis of Brain Reflexes
NCT02395861 UNKNOWN NA
PupillOmetry for Prediction of DelirIUM
NCT05248035 ACTIVE_NOT_RECRUITING